Every weekday, the CNBC Investing Club with Jim Cramer releases the Homestretch — an actionable afternoon update, just in time for the last hour of trading on Wall Street. Market update : Stocks are higher for the second session in a row. Energy is a big story on Monday, with oilfield services, refiners, and the two majors, Exxon Mobil and Chevron , rallying on the idea that they will be beneficiaries of the rebuilding of Venezuela’s oil infrastructure following the events over the weekend. The financials are also having a strong session, with Goldman Sachs , Wells Fargo , and Capital One all hitting new highs. BlackRock outperformed as well, but we decided to sell some of the position into strength to rebuild our cash position. Health care : One sector that’s sitting out the rally is health care. Danaher is having a nice session, but the pharmaceutical and biotech stocks are getting hammered. Eli Lilly , Bristol Myers , AbbVie , Johnson & Johnson , and Amgen all fell between 1% and 4%. One reason for Lilly’s drop could be news from its key competitor, Novo Nordisk . The Danish pharma company officially launched its oral GLP-1 pill for weight loss in the United States on Monday. The announcement is not a surprise, and Eli Lilly should follow in the next few months with its own launch of orforglipron, which was submitted to the FDA for approval last month. In a note on Monday, Wolfe Research said it expects orforglipron to launch in the first quarter and it is forecasting full-year sales of $3.3 billion. Oral medications have many benefits over injections, which is why we are bullish on GLP-1 adoption this year. Pills appeal to those who may be afraid to take needles. They’re also easier to ship and store than injectable medications, which typically require refrigeration. The next event we are monitoring for the group is the annual JPMorgan Healthcare Conference, which kicks off next Monday. All three health-care companies in the portfolio are scheduled to present at the event, which often features updates on acquisitions, partnerships, and fourth-quarter earnings preannouncements. Up next: There are no major earnings after the closing bell on Monday or before the opening bell on Tuesday. It’s a light day on the data side, with just the S & P Global US Services PMI. (See here for a full list of the stocks in Jim Cramer’s Charitable Trust.) As a subscriber to the CNBC Investing Club with Jim Cramer, you will receive a trade alert before Jim makes a trade. Jim waits 45 minutes after sending a trade alert before buying or selling a stock in his charitable trust’s portfolio. If Jim has talked about a stock on CNBC TV, he waits 72 hours after issuing the trade alert before executing the trade. THE ABOVE INVESTING CLUB INFORMATION IS SUBJECT TO OUR TERMS AND CONDITIONS AND PRIVACY POLICY , TOGETHER WITH OUR DISCLAIMER . NO FIDUCIARY OBLIGATION OR DUTY EXISTS, OR IS CREATED, BY VIRTUE OF YOUR RECEIPT OF ANY INFORMATION PROVIDED IN CONNECTION WITH THE INVESTING CLUB. NO SPECIFIC OUTCOME OR PROFIT IS GUARANTEED.
What may be driving Eli Lilly shares lower — plus, oil, financial stocks rally